Generation of an mESC model with a human hemophilia B nonsense mutation via CRISPR/Cas9 technology


The mutant cell line obtained in the current study had a single-base mutation rather than a base deletion or insertion in the exon, which is more similar to clinical cases. In addition, the mutant has the characteristics of mouse embryonic stem cells, and this point mutation affects F9 gene transcription and translation, which can be used as a disease model for studying the pathogenesis and treatment of hemophilia at the stem cell level. © 2022. The Author(s).

Authors Ma Y, Sun W, Zhao L, Yao M, Wu C, Su P, Yang L, Wang G
Journal Stem cell research & therapy
Publication Date 2022 Jul 26;13(1):353
PubMed 35883203
PubMed Central PMC9327398
DOI 10.1186/s13287-022-03036-2

Research Projects

Cell Lines